News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
397–432
Matches
749
Sources here
17
Companies here
20
Search results Stored financial headlines

Active search

749 matching headlines

Ticker or company: VIEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AbbVie Earnings Preview: Immunology portfolio remains in focus amid Humira decline

[AbbVie] hapabapa AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]) is projected to report a solid second-quarter print, with double-digit growth seen for both top and bottom lines. EPS is expected to go up 67% Y/Y to $3.61 [https://seekingalpha.com/symbol/ABBV/earnings/estimates]. This is the higher end of management’s forecast for the …

ABBV main company ABBV main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AbbVie Sales Beat Estimates as Botox Shows Signs of Revival

AbbVie Inc. exceeded Wall Street's second-quarter profit and sales expectations, driven by robust performance in its immunology and neuroscience divisions. The company's top-selling drugs, including the wrinkle-smoothing injection Botox, outperformed forecasts, with Botox sales showing improvement for the third consecutive quarter. Adjusted earnings also …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Riverview Bancorp, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Riverview Bancorp (NASDAQ:RVSB) recently surpassed analyst expectations for its first-quarter earnings, reporting EPS of US$0.08, beating predictions by 14%. While revenues of US$15 million were in line, the sole analyst covering the company has slightly downgraded future EPS forecasts but increased the price target …

RVSB main company
Sharemaestro market context Price below Trend Line 52 weeks +3.5% · Next-week setup negative 44.0% RVSB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VMD Q2'26 Earnings: EPS estimate is 0.12 USD

Viemed Healthcare, Inc. (VMD) is expected to announce its Q2'26 earnings on August 3rd, with an estimated EPS of $0.12 and revenue of $78.00 million. This article provides a comparative table of reported and estimated revenue and EPS figures for recent quarters, highlighting surprises.

VMD main company
Sharemaestro market context Trend signal active 52 weeks +25.9% VMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Navient Corp (NAVI) Financial Health: Profitability & Balance Sheet Analysis

Navient Corp (NAVI) currently holds a weak financial score of 4.75, ranking low in the Banking Services industry due to low operating efficiency. The company reported a significant year-over-year decrease in quarterly revenue by 12.55% and a net profit decline of 950.00%. Key financial …

JSM main company
Sharemaestro market context Price below Trend Line 52 weeks +0.8% JSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avient Corp (AVNT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Avient Corp (AVNT), detailing its volatility, financial, and investment risks. The company's current risk assessment score is 7.94, ranking 19 out of 65 in the Chemicals industry, and its beta value of 1.30 indicates higher volatility compared …

AVNT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% AVNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enterprise value to EBIT forward of Avient Corporation – NYSE:AVNT

This article focuses on the enterprise value to EBIT forward data for Avient Corporation (NYSE: AVNT). It is a financial data point available on TradingView, serving as a resource for investors interested in the company's valuation metrics within the Chemicals: Major Diversified industry. The …

AVNT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% AVNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AbbVie Inc. stock outperforms competitors despite losses on the day

AbbVie Inc. (ABBV) shares declined by 2.24% to $257.41, breaking a two-day winning streak, despite an overall positive trading day for the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average saw gains on Thursday. This report highlights AbbVie's performance …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Highview Merger Ord Shs Class A (HVMC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Highview Merger Ord Shs Class A (HVMC), focusing on various risk metrics. It includes data points such as Beta vs S&P 500 index, Maximum Drawdown, Realised Volatility, and Liquidity. The report details several financial indicators for different …

HVMC main company
Sharemaestro market context Trend signal active 46 weeks +2.6% HVMC stored weekly price path from 3 Oct 2025 to 14 Aug 2026

Veolia Environnement SA (VEOEF) (H1 2026) Earnings Call Highlights: Strong Net Income Growth ...

This article first appeared on GuruFocus. Revenue: 22.93 billion, up 1.5% at constant scope and forex (excluding energy prices). EBITDA: 3.552 billion, up 5% at constant scope and forex. EBITDA Margin: 16.0%, an increase of 70 basis points. Current Net Income: Up 10.4% at …

VIE main company VIE main company
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup positive 58.3% VIE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What To Expect From AbbVie’s (ABBV) Q2 Earnings

What To Expect From AbbVie's (ABBV) Q2 Earnings Pharmaceutical company AbbVie (NYSE:ABBV) will be announcing earnings results this Friday before market hours. Here's what to look for. AbbVie beat analysts' revenue expectations last quarter, reporting revenues of $15 billion, up 12.4% year on year. …

ABBV main company ABBV main company ABBV34 main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Preview: Navient (NAVI) Q2 Earnings Expected to Decline

Navient (NAVI) is expected to report a year-over-year decline in Q2 earnings and revenues. The consensus EPS estimate has been revised 18.16% lower, and the stock currently has an Earnings ESP of -6.76% and a Zacks Rank of #3, making an earnings beat difficult …

JSM main company NAVI main company
Sharemaestro market context Price below Trend Line 52 weeks +0.8% JSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Very Solid H1 Performance Confirming Strength of Veolia Business Model

Improved 2026 guidance A new semester of excellent performance, with +70bps EBITDA margin improvement and +10.4%(1) progression of current net income(2) Veolia is standing out in a volatile macro and geopolitical environment, with continuously improving results, thanks to solid operational execution and unique combination …

VIE main company VIE main company
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup positive 58.3% VIE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

JUVÉDERM marks 20 years since FDA approval with buy-one-get-one $75 cards

AbbVie's Allergan Aesthetics announced the fourth annual JUVÉDERM® Day will occur on August 19, 2026, coinciding with the 20th anniversary of the brand's first U.S. FDA dermal filler approval. Allē members can access a buy-one-get-one $75 JUVÉDERM® gift card promotion and double Allē points …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veolia Expands in Energy for Data Centers in the U.S., Selected to Operate a 350-MW Grid-Independent Microgrid

NEW ALBANY, Ohio, July 30, 2026--(BUSINESS WIRE)--Veolia, a global leader in environmental services, has been selected by a major project developer to operate and maintain a 350-megawatt microgrid to power an AI data center campus. This contract builds on Veolia's Data Center Resource 360 …

VIE main company VIE main company
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup positive 58.3% VIE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

JUVÉDERM® Day Returns to U.S. on August 19

Allergan Aesthetics celebrates fourth annual JUVÉDERM®Day with buy-one-get-one (BOGO) gift cards and double points for Allē Members This summer marks the 20th anniversary of the brand's first U.S. Food and Drug Administration (FDA) dermal filler approval Join Allē today to take advantage of limited …

ABBV main company ABBV main company ABBV34 main company ABBV main company ABBV main company
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FrontView REIT (FVR) Projected to Release Quarterly Earnings on Thursday

FrontView REIT (NYSE: FVR) is expected to announce its Q2 2026 earnings on Thursday, August 6th, with analysts forecasting earnings of $0.0131 per share on revenue of $18.3 million. The company recently paid a quarterly dividend of $0.215 per share, representing an annualized yield …

FVR main company
Sharemaestro market context Trend signal active 52 weeks +49.8% · Next-week setup positive 59.5% FVR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Riverview Bancorp Inc (RVSB) Financial Health: Profitability & Balance Sheet Analysis

Riverview Bancorp Inc (RVSB) has a robust financial status with a current financial score of 6.64, ranking 263 out of 394 in the Banking Services industry. The company exhibits high operating efficiency, reporting a quarterly revenue of $14.92 million, a 13.13% year-over-year increase, and …

RVSB main company
Sharemaestro market context Price below Trend Line 52 weeks +3.5% · Next-week setup negative 44.0% RVSB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Brightview Holdings Inc (BV) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Brightview Holdings Inc (BV), noting its current valuation score of 7.92, ranking 118 out of 159 in its industry. The company's P/E ratio is 439.75, which is 11.49% below its recent high and significantly above its recent …

BV main company
Sharemaestro market context Trend signal ended 52 weeks -21.1% BV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viemed Healthcare Inc (VMD) Financial Health: Profitability & Balance Sheet Analysis

Viemed Healthcare Inc (VMD) currently holds a financial score of 8.51, ranking 14th out of 75 in the Healthcare Providers & Services industry, indicating robust financial health and high operating efficiency. The company's financials, including profitability, balance sheet, and cash flow, contribute to this …

VMD main company
Sharemaestro market context Trend signal active 52 weeks +25.9% VMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avient Corporation (NYSE:AVNT) Given Consensus Recommendation of "Hold" by Brokerages

Avient Corporation (NYSE:AVNT) has received a "Hold" consensus recommendation from brokerages, with an average 12-month target price of $45.7143. Several analysts recently issued ratings, mostly "buy" or "hold," and the company reported Q4 earnings that beat estimates and announced a quarterly dividend of $0.275 …

AVNT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% AVNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veolia Strengthens Its Leadership in Latin America with a Landmark Water Contract in Colombia to Modernize Cúcuta’s Water Infrastructure

An average annual revenue of around €100 million over 20 years, representing an estimated €2 billion backlog. A major milestone reinforcing Colombia as a strategic market for Veolia in Latin America. Water losses reduction from the current 42% to below 30%, bringing Cúcuta's water …

VIE main company VIE main company
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup positive 58.3% VIE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Navient Corp (NAVI) Institutional Confidence

Navient Corp (NAVI) has an institutional shareholding score of 10.00, placing it first in the Banking Services industry. The latest institutional shareholding proportion is 110.21%, showing a 5.42% quarter-over-quarter increase. HOTCHKIS & WILEY is the largest institutional shareholder, holding 1.42 million shares.

JSM main company
Sharemaestro market context Price below Trend Line 52 weeks +0.8% JSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context